Imara begins dosing in Phase IIb sickle cell disease trial
Sickle cell disease (SCD) is a genetic blood disorder that alters red blood cells. Credit: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more